Results 81 to 90 of about 21,048 (272)
Endogenous opioid peptides and the control of pain [PDF]
, 1979 H. W. Kosterlitz
openalex +1 more source
The Long Arc of Substance Use Policy Innovation in Medicaid: Looking Back, Looking Forward
The Milbank Quarterly, EarlyView.Policy Points The role of Medicaid in financing, organizing, and delivering substance use disorder (SUD) treatment has grown tremendously over time owing to expansions of eligibility and a push toward more uniformity in benefits. Current innovations in SUD treatment focus on expanding the delivery system to create a comprehensive continuum of care ...
BRENDAN SALONER
wiley +1 more source
Molecular docking study of Papaver alkaloids to some alkaloid receptors [PDF]
Research Journal of Pharmacognosy, 2017 Background and objectives: More than 40 different alkaloids have been obtained from opium the most important of which are morphine, codeine, papaverine, noscapine and tabaine.
A. Nofallah +3 more
doaj
In Vivo Regulation of the μ Opioid Receptor: Role of the Endogenous Opioid Agents
Molecular Medicine, 2013 It is well known that genotypic differences can account for the subject-specific responses to opiate administration. In this regard, the basal activity of the endogenous system (either at the receptor or ligand level) can modulate the effects of ...
Veronica Gonzalez-Nunez +3 more
doaj +1 more source
Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas. [PDF]
J Neuroinflammation, 2022 Mousa SA +5 more
europepmc +1 more source
Allergy, EarlyView.ABSTRACT Drug‐induced immune reactions are an important burden for patients and health systems. They can be classified into immediate‐drug hypersensitivity reactions (IDHRs) and delayed‐DHRs (DDHRs) based on their phenotype. Drugs do not always behave as allergens and need to bind to proteins, forming adducts.
C. Mayorga +7 more
wiley +1 more source
British Journal of Pharmacology, EarlyView.Background and Purpose Most older people use polypharmacy (≥5 medications), particularly those with cardiovascular disease. The effects of polypharmacy on the cardiovascular system are not well described. We examined the effect of a chronic polypharmacy regimen on left ventricular (LV) function, structure and proteome in young and old mice of both ...
Trang Tran +9 more
wiley +1 more source
Interleukin-4 Induces the Release of Opioid Peptides from M1 Macrophages in Pathological Pain. [PDF]
J Neurosci, 2021 Labuz D +3 more
europepmc +1 more source
Evidence for a Dual Mechanism in the Anesthetic Action of an Opioid Peptide [PDF]
, 1985 Barbara A. Dodson, Keith W. Miller
openalex +1 more source
British Journal of Pharmacology, EarlyView.Abstract Background and Purpose Emerging literature indicates that simultaneously targeting glucagon‐like peptide‐1 receptors (GLP‐1Rs) and neuropeptide Y receptors (Y1/Y2) may represent a new pharmacotherapeutic approach to treating opioid use disorder (OUD).
Antonia Caffrey +5 more
wiley +1 more source